SPP1 and Anxiety: In vivo, OPN treatment produced sustained neurobehavioral improvements at 28 days post‐ICH, significantly ameliorating neurological deficits, mitigating anxiety‐depressive behaviors, and enhancing spatial learning‐memory performance.